Startup articles: launches, insights, stories

Basal Insulin Market to Reach US$ 16.3 Billion by 2023, Registering a CAGR of 9.8% - mixed-reality category image

Basal insulin is a long-acting insulin used to control high blood sugar in people with diabetes. It is taken once or twice daily to provide a background level of insulin

Founded year: Not set
Funding rounds: Not set
Total funding amount: Not set

Description

Not set